Rhythm Pharmaceuticals

RYTM · NASDAQ

$90.20+$1.97 (+2.23%)TodayMarket closed ·
Prev close $88.23

Who owns RYTM

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 52.7% of RYTM’s shares.

  • RA Capital Management, LP9.7%
  • Baker Bros. Advisors LP8.2%
  • BlackRock Institutional Trust Company, N.A.6.6%
  • PRIMECAP Management Company4.6%
  • Next 6 largest institutions23.6%
  • All other shareholders47.3%
Top institutional holders of RYTM
HolderShares% of shares
RA Capital Management, LP6.67M9.73%
Baker Bros. Advisors LP5.60M8.18%
BlackRock Institutional Trust Company, N.A.4.54M6.63%
PRIMECAP Management Company3.17M4.62%
Vanguard Portfolio Management, LLC3.14M4.58%
Vanguard Capital Management, LLC3.01M4.39%
Perceptive Advisors LLC2.59M3.77%
State Street Investment Management (US)2.57M3.76%
T. Rowe Price Associates, Inc.2.49M3.63%
JP Morgan Asset Management2.36M3.44%

Largest mutual fund holders

Top mutual fund holders of RYTM
HolderShares% of shares
Vanguard Total Stock Market Index Fund2.18M3.19%
PRIMECAP Odyssey Aggressive Growth Fund1.99M2.90%
American Funds SMALLCAP World Fund1.71M2.49%
Vanguard Small-Cap Index Fund1.58M2.30%
Polar Capital Biotechnology Fund1.58M2.30%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $32.94M (22 trades) of RYTM on the open market, with no buys.

Latest RYTM insider transactions
InsiderTypeSharesValue
Meeker David POption exercise50.00K—
Meeker David PSale2.30K$241.94K
Meeker David PSale1.82K$189.96K
Meeker David PSale8.70K$899.63K
Meeker David PSale30.75K$3.15M
Meeker David PSale6.44K$655.15K
Meeker David POption exercise50.00K$302.50K
Smith Hunter COption exercise57.19K—
Smith Hunter CSale28.19K$2.99M
Smith Hunter CSale11.51K$1.21M

Short interest

Settled Sep 30, 2026

Shares short
10.77M
Days to cover
14.14
% of shares outstanding
15.71%
Average daily volume
761.71K
Change since last report
+4.7%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.